EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Patient-derived organoids and neurospheres recapitulate salient features of primary tumor heterogeneity

Zachery Moore iD, Claire Storey, Daniel V Brown iD, Adam Valkovic iD, Montana Spiteri iD, Jasmine F Pignatelli iD, Shannon J Oliver, Alana Fakhri iD, Katharine J Drummond iD, Jessica Hart, Lachlan Harris iD, Seth Malinowski iD und 5 weitere

Neuro-Oncology Advances · 12.01.2026 · 8 (1)

DOI: 10.1093/noajnl/vdaf247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 22.11.2025. Verfasst von Zachery Moore und 16 weiteren Autor:innen. Beteiligte Einrichtung: Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville (Z.M., C.S., A.V., M.S., J.F.P., S.J.O., O.M.S., J…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Brain Cancer Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractAbstract Background The intra- and inter-tumoral heterogeneity of glioblastoma (GBM) represents a significant therapeutic challenge and barrier to the generation of reliable and accurate models for in vitro studies. Three-dimensional models, such as patient-derived neurospheres (PDN) and organoids (PDO), recapitulate complex cellular states. However, the direct comparison of models derived in parallel from the same primary tumor tissue has never been performed. The aim of this study was to determine the tumor cell composition of PDN and PDO models relative to matched primary GBM tissue.

Methods

Four GBM surgical samples were used to establish matched PDO and PDN models, which were genomically verified using single nucleotide polymorphism array. DNA methylation, histology, and transcriptome were examined for intra-tumoral heterogeneity correlating with the matched GBM tissue. PDN lines were used to investigate the tumor cell composition response to temozolomide chemotherapy over time, maximizing their utility.

Results

We find that both patient-derived models recapitulate the genomic, epigenomic, and tumor cell heterogeneity of the primary tissue at similar capacity. Furthermore, single-nuclei RNA sequencing revealed a subset of organoids containing small numbers of non-malignant cells from neuron and immune cell lineages. Harnessing the intra-tumoral heterogeneity of PDN models, we reveal the impact of temozolomide chemotherapy on individual cell states, altering composition of tumors over time in response to treatment.

Conclusions

Our data confirms that both PDN and PDO patient-derived models recapitulate patient intra-tumoral heterogeneity providing a platform for tumor cell state refined therapeutic studies.

Schlagwörter

Stichwörter der Autor:innen

glioblastomaheterogeneityneurospheresorganoidssingle nuclei RNA sequencing

Autor:innen und Institutionen

  • Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville (Z.M., C.S., A.V., M.S., J.F.P., S.J.O., O.M.S., J.R.W, S.F., S.A.B.).
  • Department of Medical Biology, The University of Melbourne, Parkville (Z.M., C.S., D.V.B., O.M.S., J.R.W., S.F., S.A.B.).
  • Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville (D.V.B.).
  • Department of Neurosurgery, The Royal Melbourne Hospital, Parkville (A.F., K.J.D.).
  • Department of Surgery, The University of Melbourne, Parkville (K.J.D., O.M.S.).
  • QIMR Berghofer Medical Research Institute, Brisbane (J.H., L.H.).

ORCID-Profile: Zachery Moore, Daniel V Brown, Adam Valkovic, Montana Spiteri, Jasmine F Pignatelli, Alana Fakhri, Katharine J Drummond, Lachlan Harris, Seth Malinowski, Keith L Ligon, Oliver M Sieber, James R Whittle, Saskia Freytag, Sarah A Best

Förderung

  • Brain Cancer Centre

Zitieren

APA

Moore, Z., Storey, C., Brown, D. V., Valkovic, A., Spiteri, M., Pignatelli, J. F., Oliver, S. J., Fakhri, A., Drummond, K. J., Hart, J., Harris, L., Malinowski, S., Ligon, K. L., Sieber, O. M., Whittle, J. R., Freytag, S., & Best, S. A. (2026). Patient-derived organoids and neurospheres recapitulate salient features of primary tumor heterogeneity. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdaf247

Vancouver

Moore Z, Storey C, Brown DV, Valkovic A, Spiteri M, Pignatelli JF, et al. Patient-derived organoids and neurospheres recapitulate salient features of primary tumor heterogeneity. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdaf247

BibTeX
@article{Moore2026,
  author = {Moore, Zachery and Storey, Claire and Brown, Daniel V and Valkovic, Adam and Spiteri, Montana and Pignatelli, Jasmine F and Oliver, Shannon J and Fakhri, Alana and Drummond, Katharine J and Hart, Jessica and Harris, Lachlan and Malinowski, Seth and Ligon, Keith L and Sieber, Oliver M and Whittle, James R and Freytag, Saskia and Best, Sarah A},
  title = {Patient-derived organoids and neurospheres recapitulate salient features of primary tumor heterogeneity},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/noajnl/vdaf247}
}
Kostenlos starten →